Patents for C07H 21 - Compounds containing two or more mononucleotide units having separate phosphate or polyphosphate groups linked by saccharide radicals of nucleoside groups, e.g. nucleic acids (89,892) |
---|
09/08/2011 | US20110217703 P2/p2a/p2b gene sequences as diagnostic targets for the identification of fungal and yeast species |
09/08/2011 | US20110217695 BETAG1-IgG INTRON FOR ENHANCED ANTI-IGF1R EXPRESSON |
09/08/2011 | US20110217414 Polypeptides having tyrosinase activity and polynucleotides encoding same |
09/08/2011 | US20110217367 Means for inhibiting the expression of orc-1 |
09/08/2011 | US20110217362 Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof |
09/08/2011 | US20110217361 Group of Nucleic Acid Fragments for Prevention of HIV Infection or AIDS and the Usage Thereof |
09/08/2011 | US20110217334 Hypoallergenic molecules |
09/08/2011 | US20110217326 Method for diagnosing and/or treating tumor |
09/08/2011 | US20110217325 T cell epitopes of the cyn d 1 allergen from bermuda grass pollen |
09/08/2011 | US20110217318 Anti-platelet membrane glycoprotein vi monoclonal antibody |
09/08/2011 | US20110217316 GBS Toxin Receptor Compositions and Methods of Use |
09/08/2011 | US20110217306 C-terminal exon 5.4 of runx1/aml1 |
09/08/2011 | US20110217305 Anti-her2 antibodies and compositions |
09/08/2011 | US20110217304 Monoclonal antibodies directed to cd52 |
09/08/2011 | US20110217302 TCR Complex Immunotherapeutics |
09/08/2011 | US20110217298 Monoclonal antibodies directed to cd20 |
09/08/2011 | US20110217291 Soluble hybrid fct receptors and related methods |
09/08/2011 | US20110217290 Treatment and/or prevention of peanut induced anaphylaxis |
09/08/2011 | US20110217284 Factor IX Variants with Clotting Activity in Absence of Their Cofactor and Their Use for Treating Bleeding Disorders |
09/08/2011 | US20110217267 Gene therapy vectors and cytosine deaminases |
09/08/2011 | US20110217266 Genomic sequence of avian paramyxovirus type 2 and uses thereof |
09/08/2011 | US20110217241 Conjugates of 19f mr imaging tracers for use in multi-chromic mri imaging |
09/08/2011 | US20110217237 Therapeutic dll4 binding proteins |
09/08/2011 | US20110217235 Alpha 1-3 n-galactosyltransferase with altered donor specificities |
09/08/2011 | DE102010010052A1 Signalgebende Bindemoleküle, Vorrichtungen und Verfahren zu deren Verwendung Signaling binding molecules, devices, and methods of use thereof |
09/07/2011 | EP2363821A2 Method and device for optimising a nucleotide sequence for expressing a protein |
09/07/2011 | EP2363505A2 Diagnosis of melanoma by nucleic acid analysis |
09/07/2011 | EP2363503A1 Modulation of HIF1A and HIF2A expression |
09/07/2011 | EP2363483A2 Multiple promoter expression cassettes for simultaneous delivery of RNAi agents |
09/07/2011 | EP2363480A2 Modulation of glucocorticoid receptor expression |
09/07/2011 | EP2363404A2 PSMA antibodies |
09/07/2011 | EP2363403A2 Isolation of five novel genes coding for new fc receptors-type melanoma involved in the pathogenesis of lymphoma/melanoma |
09/07/2011 | EP2363141A1 Compsition comprising two oligonucleotides linked directly at their 3'ends wherein at leat one oligonucleotide has an accessible 5'end and the compound further comprising IL-2 used for synergistically stimulating an immune response in a patient. |
09/07/2011 | EP2362907A2 Nucleic acid extraction on curved glass surfaces |
09/07/2011 | EP2362877A2 Polynucleotides encoding a human trim-cyp fusion polypeptide, compositions thereof, and methods of using same |
09/07/2011 | EP0871646B1 Dna sequencing by parallel oligonucleotide extensions |
09/07/2011 | CN102177233A Virus-like particles comprising composite capsid amino acid sequences for enhanced cross reactivity |
09/07/2011 | CN102177178A Anti-IL-12/IL-23 antibodies |
09/07/2011 | CN102174538A Detection of mutations in a gene associated with resistance to viral infection, oas1 |
09/07/2011 | CN102174490A Expression of granular starch hydrolyzing enzymes in trichoderma and process for producing glucose from granular starch substrates |
09/07/2011 | CN102174092A ABA (abscisic acid) and salt related protein STS1 (steroid sulfatase 1) and encoding genes and application thereof |
09/07/2011 | CN101612541B Preparation of polyacrylic acid coated ferroferric oxide magnetic nano-particles and application thereof |
09/07/2011 | CN101220360B SiRNA sequence restraining caspase-3 gene expression |
09/07/2011 | CN101037691B CENP-E combined protein and encoding gene and application |
09/06/2011 | US8014955 Method of identifying unique target sequence |
09/06/2011 | US8013216 Using vector transformation to generate transgenic brassica with enhanced Delta 6-C18-fatty acid content; plant oil comprising improved nutraceutical content |
09/06/2011 | US8013212 Site-specific recombination in eukaryotes and constructs useful therefor |
09/06/2011 | US8013147 Heterocyclic compounds and their use in the detection of nucleic acids |
09/06/2011 | US8013146 RNA interference mediated inhibition of matrix metalloproteinase 13 (MMP13) gene expression using short interfering nucleic acid (siNA) |
09/06/2011 | US8013145 efficient sequence specific gene silencing; gene expression inhibition; increases siRNA efficacy |
09/06/2011 | US8013144 hnRNP K expression-inhibiting compound and siRNA sequence thereof |
09/06/2011 | US8013143 Chemically synthesized nucleic acid molecule with a pyrimidine modification; cancer, ocular disease, and other proliferative disorders; neovascularization, diabetic retinopathy, restenosis and polycystic kidney disease |
09/06/2011 | US8013142 Compositions for use in identification of bacteria |
09/06/2011 | US8013141 Promoter with high expression strength and over-expression in various tissues of plant, as well as application thereof |
09/06/2011 | US8013140 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof |
09/06/2011 | US8013139 Promoter for introducing a gene into a lymphocyte or blood cell and application thereof |
09/06/2011 | US8013136 Oligonucleotides comprising a non-phosphate backbone linkage |
09/06/2011 | US8013135 Antibodies and molecules derived therefrom that bind to STEAP-1 proteins |
09/06/2011 | US8013134 Kit for proximity probing with multivalent proximity probes |
09/06/2011 | US8013133 Genetic modification of targeted regions of the cardiac conduction system |
09/06/2011 | US8012948 Fas/FasL or other death receptor targeted methods and compositions for killing tumor cells |
09/06/2011 | US8012947 Methods and compositions for promoting wound healing |
09/06/2011 | US8012931 Modified FGF-21 polypeptides and their uses |
09/06/2011 | US8012756 Charge perturbation detection system for DNA and other molecules |
09/06/2011 | US8012748 Peripheral nervous system specific sodium channel nucleic acids |
09/06/2011 | US8012734 Cellulase variants with reduced inhibition by glucose |
09/06/2011 | US8012732 Fungal lypolytic and amylase enzyme composition and methods using the same |
09/06/2011 | US8012731 Phosphodiesterase and gene thereof |
09/06/2011 | US8012730 Specific lysis of staphylococcal pathogens by bacteriophage phi11 endolysin |
09/06/2011 | US8012729 Mutant glucose dehydrogenase |
09/06/2011 | US8012726 Method of making bioethanol by using glucose isomerase mutants |
09/06/2011 | US8012725 Method for the production of optically-active alcohols |
09/06/2011 | US8012690 Enriching for sequestered populations of amplified nucleic acid molecules; immobilizing preferential nucleotide sequences onto beads, replicating sequences, recovering propagated nucleotide sequences |
09/06/2011 | US8012689 Elite event A2407-12 and methods and kits for identifying such event in biological samples |
09/06/2011 | US8012687 Isolated genomic polynucleotide fragments from chromosome 19 that encode human resistin and the human syntaxin binding protein 2 |
09/06/2011 | US8012686 Risk assessment for adverse drug reactions |
09/06/2011 | US8012685 Detection of analytes and nucleic acids |
09/06/2011 | US8012684 Mutated AQP, method for detecting cancer using the same, DNA chip having oligonucleotides of said mutated AQP sequence |
09/06/2011 | US8012681 co-culturing cancer cells and host cells for a time sufficient to detect evidence of gene expression in co-culture for simulating the progression from a primary tumor to a metastasis in an in vitro model; anti-EphA2 ( epithelial cell kinase) antibody |
09/06/2011 | US8012680 Microchip, nucleic acid extracting kit, and nucleic acid extracting method |
09/06/2011 | US8012482 Humanized anti-TGF-beta antibodies |
09/06/2011 | US8012464 Chimeric colony stimulating factor for use in treatment and prevention of cell proliferative, blood, inflammatory and nervous system disorders |
09/01/2011 | WO2011106689A1 Modulation of smad3 expression |
09/01/2011 | WO2011106583A1 Polytag probes |
09/01/2011 | WO2011106456A2 Artificial mycolic acid membranes |
09/01/2011 | WO2011106314A2 Method of making nucleic acid libraries |
09/01/2011 | WO2011105654A1 Y-probe and variation thereof, and dna microarray, kit, and gene analysis method using the y-probe and the variation thereof |
09/01/2011 | WO2011061373A8 Quantification of bovine polyomavirus (bpyv) for tracing bovine contamination in the environment |
09/01/2011 | US20110214209 Modified bacillus thuringiensis cry12 proteins for nematode control |
09/01/2011 | US20110214208 Modified Bacillus Thuringiensis Cry5 Proteins For Nematode Control |
09/01/2011 | US20110214206 Nucleic acid molecules and other molecules associated with plants |
09/01/2011 | US20110214204 Polynucleotides encoding proteins involved in plant metabolism |
09/01/2011 | US20110214203 Sugar and lipid metabolism regulators in plants ii |
09/01/2011 | US20110214202 CVYV-Resistant Plants of the Species Cucumis Melo |
09/01/2011 | US20110214201 Method for Producing Haploid, Doubled Haploid and/or Dihaploid Plants by Gynogenesis |
09/01/2011 | US20110214200 Yield traits for maize |
09/01/2011 | US20110214192 Photoconvertible fluorescent proteins |
09/01/2011 | US20110213337 Methods for the early diagnosis of ovarian cancer |
09/01/2011 | US20110213136 Antisense modulation of stearoyl-coa desaturase expression |
09/01/2011 | US20110213135 Cytotoxic Nucleotides for Targeted Therapeutics |